Submitted by Anonymous (not verified) on 24 June 2025 - 14:48
Opinion/decision on a Paediatric investigation plan (PIP): Entyvio, vedolizumab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Gastrointestinal disorders, PIP number: P/0244/2024
Source: